ANS-CVS 2 Flashcards

1
Q

Example of muscarinic receptors agonist

A
  1. pilocarpine (use as eye drop to treat glaucoma)2. bethanechol
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Example of muscarinic receptors antagonist

A

Atropine (treat bradycardia)hyoscine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Indirect acting of cholinergic agonist

A

Action of cholinesterase inhibitors (inhibit Ach catabolism)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Types of cholinesterase inhibitors

A
  1. Carbamates (physostigmine, neostigmine)2. Phosphates (isofluorophate)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Two type of cholinergic agonist

A
  1. Choline esters (Ach, bethanechol)2. Alkaloids (pilocarpine)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What are the effects produced by muscarinic agonists?

A

Parasympathetic-like effects.1. Smooth muscle (M1) - Increase GI peristaltic activity2. Cardiovascular (M2) - Cardiac slowing, decrease c. output3. Eye (M3) - Contraction of ciliary muscle4. Secretions (M3) - Stimulation of exocrine glands, sweating, lacrimation, salivation and bronchial secretion.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

what is glaucoma?

A

increase intraocular pressure due to increase aqueous fluid production and decreased its trabecular outflow.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Effects produced by muscarinic antagonists

A

Sympathetic-like effects1. Smooth muscle (M1) - Bronchial, biliary & urinary tract SM relax. GI transit is inhibited2. Cardiovascular (M2) - Tachycardia3. Eye (M3) - Dilation of the pupil and relaxation of ciliary muscle4. Secrettions (M3) - Inhibition of secretions; dry mouth, bronchial mucociliary clearance is inhibited.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Therapeutic uses of muscarinic antagonists

A
  1. GI actions: - treat hyermotility and spasm associated with GI disease (IBS) - Dicycloverine2. Resp. actions: - Treatment of COPD and acute asthma; as bronchodilator - Ipratropium3. Urinary tract: - relieve muscle spasm accompanying infection4. CVS actions: - Treating bradycardia associated with MI - Atropine 5. Overactive bladder: - Reduce spontaneous myocyte activity - decrease frequency and intensity of detrusor activity - M3 receptor antagonists - Adverse reaction - dry mouth, constipation, blurred vision, cardiac arrhythmia
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Botulinum toxin..

A
  • Botulinum toxin A (BTX-A) most potent and have a longer duration of action- Administered and act in a site specific manner
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Type of neuromuscular blocking drugs

A
  1. Non depolarising: Block Ach receptors2. Depolarising: Agonists at Ach receptors
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Examples of competitive antagonists of Ach at mNicotinic receptor:

A

Tubocurarine analogues1. Mivacurium2. Atracurium3. Vecuronium4. Pancuronium

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

How depolarising agent act as neuromuscular blocking drugs?

A
  • Sustained mNicotinic agonism at NMJ -> depolarisation block
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Depolarising agent (suxamethonium) is contraindicated in..

A
  1. Neuropathies2. Myopathies (esp malignant hyperthermia)3. Burns/severe trauma (hyperkalaemia -> risk of arrhythmia)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Example of AchE inhibitors (indirect cholinergic agonist)

A
  1. Short-acting quaternary alcohols: - e.g. edrophonium - Bind to anionic site -> prevent Ach access - Readily reversible -> brief action - Used in diagnosis of myasthenia gravis2. Medium acting Carbamyl esters - e.g. neostigmine, physostigmine (longer acting) - Carbamyl transfer to anionic site, then slow hydrolysis - As reversal of NMJ block, myasthenia treatment - Also Alzheimer’s (doneprezil, tacrine)3. Irreversible block - e.g. echothiopate (eye drop for glaucoma), dyflos, melathion - Phosphorylate ser203 at active site; stable bond so long lasting - Reversible within first 1-2 hours using pralidoxome
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Example of direct acting adrenoreceptor agonists

A
  1. dobutamine2. epinephrine3. phenylephrine
17
Q

Example of beta blockers

A
  1. Atenolol2. Propanolol
18
Q

dobutamine

A
  1. direct adrenoceptor agonist2. Effects: - Cardiac stimulation (B1) - Vasodilation (B2)3. clinical use: - cardiogenic shock - acute heart failure - cardiac stimulation during heart surgery4. side effect - arrhythmias
19
Q

epinephrine

A
  1. Effects: - Vasoconstriction and increase BP (a1) - Cardiac stimulation (B1) - Bronchodilation (B2)2. Side effects: - Hypertension - Vasoconstriction - Arrhythmias
20
Q

Example of indirect acting adrenoreceptor agonists

A
  1. amphetamine2. cocaine3. ephedrine
21
Q

cocaine

A
  1. Effects: - Inhibition of norepinephrine reuptake2. Side effects: - hypertension - cardiac damage - necrosis of nasal mucosa (abuse)
22
Q

ephedrine

A
  1. Effects: - vasoconstriction (a1)2. Clinical use - nasal decongestion3. Side effects: - hypertension - tachycardia - insomnia
23
Q

phenylephrine

A
  1. Effects: - Vasoconstriction, increase BP, mydriasis (a1)2. Side effects: - Bradycardia - Hypertension
24
Q

amphetamine

A
  1. Effects: - increase norepinephrine release 2. Side effects: - hypertension - tachycardia - dependence
25
Q

Examples of a-blockers

A
  1. Prazosin 2. Phentolamine
26
Q

prazosin

A
  1. MOA: competitive a1-blocker2. Effects: - vasodilation - decrease vascular resistance and BP - relax bladder neck and prostate3. Clinical use: hypertension4. Side effects: - hypotension - tachycardia - nasal congestion
27
Q

phentolamine

A
  1. MOA: competitive a1 and a2 blocker2. Effects: - Vasodilation - Decrease vascular resistance and BP3. Side effects: - Hypotension - tachycardia - nasal congestion
28
Q

atenolol

A
  1. MOA: B1-blocker2. Effects: - decrease cardiac rate, output, AV node conduction & O2 demand - decrease blood pressure3. Clinical use: hypertension, angina, acute MI, arrhythmia4. Side effects: - Cardiac failure - Bronchoconstriction
29
Q

propanolol

A
  1. MOA: B1 and B2 blocker2. Effects: - decrease cardiac ratem otput, AV node conduction & O2 demand - decrease blood pressure3. Clinical use: hypertension, angina, arrhythmia, acute MI4. Side effects: - cardiac failure - bronchoconstriction
30
Q

Example a & b blockers

A

Cervedilol

31
Q

carvedilol

A
  1. MOA: - B1 and B2 blocker - a1 blocker2. Effects: - Vasodilation - decrease heart rate and BP in patient with hypertension - increase cardiac output in patient with heart failure